NEULAND LABORATORIES
Back to Income Statement
|
NEULAND LABORATORIES Last 5 Year Earnings Per Share (EPS) History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Adjusted EPS | ₹202.74 | ₹233.89 | ₹127.45 | ₹49.74 | ₹62.85 |
What is the latest Earnings Per Share (EPS) of NEULAND LABORATORIES ?
| Year | Earnings Per Share (EPS) |
|---|---|
| Mar2025 | ₹202.74 |
| Mar2024 | ₹233.89 |
| Mar2023 | ₹127.45 |
| Mar2022 | ₹49.74 |
| Mar2021 | ₹62.85 |
How is Earnings Per Share (EPS) of NEULAND LABORATORIES Trending?
| Years | Earnings Per Share (EPS) | % Change | |
|---|---|---|---|
| Mar2025 | ₹202.74 | -13.32 | |
| Mar2024 | ₹233.89 | 83.52 | |
| Mar2023 | ₹127.45 | 156.23 | |
| Mar2022 | ₹49.74 | -20.86 | |
| Mar2021 | ₹62.85 | - | |
Compare Earnings Per Share (EPS) of peers of NEULAND LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| NEULAND LABORATORIES | ₹14,783.7 Cr | -2% | -11.8% | 11.8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹421,407.0 Cr | -0.3% | 3.1% | 2.2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹159,596.0 Cr | 0.5% | -2.9% | 5.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹142,619.0 Cr | 0.1% | 1.4% | 37.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹104,544.0 Cr | 1.9% | 1.4% | 10.7% | Stock Analytics | |
| CIPLA | ₹98,767.6 Cr | -3.3% | -6.9% | -17% | Stock Analytics | |
NEULAND LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| NEULAND LABORATORIES | -2% |
-11.8% |
11.8% |
| SENSEX | -3.7% |
-13.2% |
-2% |
You may also like the below Video Courses